Cargando…

Vaccine hesitancy: the next challenge in the fight against COVID-19

Vaccine hesitancy remains a barrier to full population inoculation against highly infectious diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns about the safety of such a vaccine could contribute to vaccine hesitancy. We analyzed 1941 anonymous questionnaires co...

Descripción completa

Detalles Bibliográficos
Autores principales: Dror, Amiel A., Eisenbach, Netanel, Taiber, Shahar, Morozov, Nicole G., Mizrachi, Matti, Zigron, Asaf, Srouji, Samer, Sela, Eyal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851308/
https://www.ncbi.nlm.nih.gov/pubmed/32785815
http://dx.doi.org/10.1007/s10654-020-00671-y
_version_ 1784652795312340992
author Dror, Amiel A.
Eisenbach, Netanel
Taiber, Shahar
Morozov, Nicole G.
Mizrachi, Matti
Zigron, Asaf
Srouji, Samer
Sela, Eyal
author_facet Dror, Amiel A.
Eisenbach, Netanel
Taiber, Shahar
Morozov, Nicole G.
Mizrachi, Matti
Zigron, Asaf
Srouji, Samer
Sela, Eyal
author_sort Dror, Amiel A.
collection PubMed
description Vaccine hesitancy remains a barrier to full population inoculation against highly infectious diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns about the safety of such a vaccine could contribute to vaccine hesitancy. We analyzed 1941 anonymous questionnaires completed by healthcare workers and members of the general Israeli population, regarding acceptance of a potential COVID-19 vaccine. Our results indicate that healthcare staff involved in the care of COVID-19 positive patients, and individuals considering themselves at risk of disease, were more likely to self-report acquiescence to COVID-19 vaccination if and when available. In contrast, parents, nurses, and medical workers not caring for SARS-CoV-2 positive patients expressed higher levels of vaccine hesitancy. Interventional educational campaigns targeted towards populations at risk of vaccine hesitancy are therefore urgently needed to combat misinformation and avoid low inoculation rates.
format Online
Article
Text
id pubmed-8851308
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-88513082022-02-18 Vaccine hesitancy: the next challenge in the fight against COVID-19 Dror, Amiel A. Eisenbach, Netanel Taiber, Shahar Morozov, Nicole G. Mizrachi, Matti Zigron, Asaf Srouji, Samer Sela, Eyal Eur J Epidemiol Vaccine Hesitancy Vaccine hesitancy remains a barrier to full population inoculation against highly infectious diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns about the safety of such a vaccine could contribute to vaccine hesitancy. We analyzed 1941 anonymous questionnaires completed by healthcare workers and members of the general Israeli population, regarding acceptance of a potential COVID-19 vaccine. Our results indicate that healthcare staff involved in the care of COVID-19 positive patients, and individuals considering themselves at risk of disease, were more likely to self-report acquiescence to COVID-19 vaccination if and when available. In contrast, parents, nurses, and medical workers not caring for SARS-CoV-2 positive patients expressed higher levels of vaccine hesitancy. Interventional educational campaigns targeted towards populations at risk of vaccine hesitancy are therefore urgently needed to combat misinformation and avoid low inoculation rates. Springer Netherlands 2020-08-12 2020 /pmc/articles/PMC8851308/ /pubmed/32785815 http://dx.doi.org/10.1007/s10654-020-00671-y Text en © Springer Nature B.V. 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Vaccine Hesitancy
Dror, Amiel A.
Eisenbach, Netanel
Taiber, Shahar
Morozov, Nicole G.
Mizrachi, Matti
Zigron, Asaf
Srouji, Samer
Sela, Eyal
Vaccine hesitancy: the next challenge in the fight against COVID-19
title Vaccine hesitancy: the next challenge in the fight against COVID-19
title_full Vaccine hesitancy: the next challenge in the fight against COVID-19
title_fullStr Vaccine hesitancy: the next challenge in the fight against COVID-19
title_full_unstemmed Vaccine hesitancy: the next challenge in the fight against COVID-19
title_short Vaccine hesitancy: the next challenge in the fight against COVID-19
title_sort vaccine hesitancy: the next challenge in the fight against covid-19
topic Vaccine Hesitancy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851308/
https://www.ncbi.nlm.nih.gov/pubmed/32785815
http://dx.doi.org/10.1007/s10654-020-00671-y
work_keys_str_mv AT droramiela vaccinehesitancythenextchallengeinthefightagainstcovid19
AT eisenbachnetanel vaccinehesitancythenextchallengeinthefightagainstcovid19
AT taibershahar vaccinehesitancythenextchallengeinthefightagainstcovid19
AT morozovnicoleg vaccinehesitancythenextchallengeinthefightagainstcovid19
AT mizrachimatti vaccinehesitancythenextchallengeinthefightagainstcovid19
AT zigronasaf vaccinehesitancythenextchallengeinthefightagainstcovid19
AT sroujisamer vaccinehesitancythenextchallengeinthefightagainstcovid19
AT selaeyal vaccinehesitancythenextchallengeinthefightagainstcovid19